Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Short-term Investments (2016 - 2025)

Historic Short-term Investments for Gyre Therapeutics (GYRE) over the last 15 years, with Q3 2025 value amounting to $19.6 million.

  • Gyre Therapeutics' Short-term Investments rose 11295.25% to $19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.6 million, marking a year-over-year increase of 11295.25%. This contributed to the annual value of $14.9 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Gyre Therapeutics reported Short-term Investments of $19.6 million as of Q3 2025, which was up 11295.25% from $17.9 million recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Short-term Investments ranged from a high of $24.0 million in Q1 2021 and a low of $2.5 million during Q4 2021
  • Moreover, its 3-year median value for Short-term Investments was $12.9 million (2021), whereas its average is $12.5 million.
  • In the last 5 years, Gyre Therapeutics' Short-term Investments plummeted by 9488.92% in 2021 and then surged by 11295.25% in 2025.
  • Quarter analysis of 3 years shows Gyre Therapeutics' Short-term Investments stood at $2.5 million in 2021, then surged by 495.05% to $14.9 million in 2024, then surged by 31.86% to $19.6 million in 2025.
  • Its Short-term Investments was $19.6 million in Q3 2025, compared to $17.9 million in Q2 2025 and $14.8 million in Q1 2025.